Allelic Diversity of the Hemochromatosis Gene (HFE) in Malays, Chinese and Indians

Main Article Content

Che Ghazali Norul Hajar
Suhaida Md Akhir
Zulkafli Zefarina
Nor Suhaila Md. Riffin
Tuan Hulwani Tuan Mohammad
Sabreena Safuan
Mohd Nazri Hassan
Mohd Yusmaidie Aziz
Siddhartha Pati
Geoffrey Keith Chambers
Hisham Atan Edinur

Abstract

Introduction: Hereditary hemochromatosis (HH) is an autosomal recessive disorder that causes accumulation of iron in circulating blood and organs. The disease is associated with H63D, S65C and C282Y variants of the haemochromatosis (HFE) gene and, if not treated can cause organ damage and may prove fatal. The main objectives of the present survey were to screen these genetic variants and establish risk profiles for developing HH in Malays, Chinese and Indians. Methods: A total of two hundred and twenty-two unrelated and healthy individuals together representing Malay, Chinese and Indian ethnicities in Malaysia were scored for the H63D, S65C and C282Y variants using a polymerase chain reaction-restriction fragment length polymorphism technique. Results: There are clear differences in H63D, S65C and C282Y allele and genotype frequency distributions between Malays, Chinese and Indians. In particular, H63D is more common in Chinese (5.19%) and Indians (7.29%), while S65C is more common in Malays (1.03%) and Chinese (1.04%). In addition, a susceptibility genotype for HH (the compound heterozygote for C282Y and H63D) was only detected in Indians (0.02%). Conclusion: Overall, our study is the first to provide data on the prevalence of H63D, S65C, and C282Y genetic variants and HH risk profiles for Malays, Chinese and Indians.

Downloads

Download data is not yet available.

Article Details

How to Cite
Norul Hajar, C. G., Md Akhir, S., Zefarina, Z., Md. Riffin, N. S., Tuan Mohammad, T. H., Safuan, S., Hassan, M. N., Aziz, M. Y., Pati, S., Chambers, G. K., & Edinur, H. A. (2021). Allelic Diversity of the Hemochromatosis Gene (HFE) in Malays, Chinese and Indians. Malaysian Journal of Medicine and Health Sciences, 17(3), 49–54. Retrieved from http://mjmhsojs.upm.edu.my/index.php/mjmhs/article/view/391
Section
Original Articles

References

Pietrangelo A. Hereditary hemochromatosis. Annu Rev Nutr. 2006;26:251-70.

Pelusi C, Gasparini DI, Bianchi N, Pasquali R. Endocrine dysfunction in hereditary hemochromatosis. J Endocrinol Invest. 2016;39(8):837-47.

Porter JL, Rawla P. Hemochromatosis [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 [cited 2020 July 06]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK430862/

Palmer WC, Vishnu P, Sanchez W, Aqel B, Riegert- Johnson D, Seaman LAK, et al. Diagnosis and management of genetic iron overload disorders. J Gen Intern Med. 2018;33(12):2230-6.

Beutler E, Felitti V, Gelbart T, Ho N. The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic. Ann Intern Med. 2000;133(5):329-37.

Cox TM, Kelly AL. Haemochromatosis: an inherited metal and toxicity syndrome. Curr Opin Genet Dev. 1998;8(3):274-81.

Bacon BR, Powell LW, Adams PC, Kresina TF, Hoofnagle JH. Molecular medicine and hemochromatosis: at the crossroads. Gastroenterology. 1999;116(1):193-207.

Mura C, Raguenes O, Ferec C. HFE mutations analysis in 711 hemochromatosis probands: evidence for S65C implication in mild form of hemochromatosis. Blood. 1999;93(8):2502-5.

Holmström P, Marmur J, Eggertsen G, Gafvels M, Stal P. Mild iron overload in patients carrying the HFE S65C gene mutation: a retrospective study in patients with suspected iron overload and healthy controls. Gut. 2002;51(5):723-30.

Limdi JK, Crampton JR. Hereditary haemochromatosis. QJM. 2004;97(6):315-24.

Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJ. Global prevalence of putative haemochromatosis mutations. J Med Genet. 1997;34(4):275-78.

Spínola C, Brehm A, Spínola H. Prevalence of H63D, S65C, and C282Y hereditary hemochromatosis gene variants in Madeira Island (Portugal). Ann Hematol. 2011;90(1):29-32.

Nielsen P, Carpinteiro S, Fischer R, Cabeda JM, Porto G, Gabbe EE. Prevalence of the C282Y and H63D mutations in the HFE gene in patients with hereditary haemochromatosis and in control subjects from Northern Germany. Br J Haematol. 1998;103(3):842-5.

Merryweather-Clarke AT, Pointon JJ, Jouanolle AM, Rochette J, Robson KJ. Geography of HFE C282Y and H63D mutations. Genet Test. 2000;4(2):183- 98.

Hajar CGN, Zulkafli Z, Riffin NSM, Mohammad THT, Safuan S, Nelson BR, et al. Human neutrophil antigen frequency data for Malays, Chinese and Indians. Transfus Apher Sci. 2020;59(2):102651.

Hajar CGN, Zefarina Z, Riffin NSM, Mohammad THT, Hassan MN, Dafalla AM, et al. Human platelet antigen datasets for Malays, Chinese, and Indians in Peninsular Malaysia. Ann Lab Med. 2020;40(6):493-9.

Hajar CGN, Zefarina Z, Riffin NSM, MohammadTHT, Hassan MN, Poonachi P, et al. Extended blood group profiles for Malays, Chinese and Indians in Peninsular Malaysia. Egypt J Med HumGenet. 2020; 21(1):1-10.

Norman PJ, Tau S, Kichula K, Harisson G, Farias TDJ, Zefarina Z, et al. The combinatorial diversity of KIR and HLA class I allotypes in Peninsular Malaysia. Immunology. 2020; 162(4):389-404.

Morra A, Böhringer S, van der Vaart A. A Goodness- of-fit test for Hardy-Weinberg Equilibrium in the presence of Covariates. Rapenburg, Leiden University 2016 [retrieved on 2020 April 12]. Available from: https://www.math.leidenuniv.nl/scripties/MasterMorra.pdf

Stangroom J. Goodness-of-fit test calculator. Social science statistics [accessed on 2020 April 2]. Available from: http://www socscistatistics com/tests/fisher/default2 aspx.

Steck AK, Rewers MJ. Genetics of type 1 diabetes. Clin Chem. 2011;57(2):176-85.

Cai W, Yin L, Yang F, Zhang L, Cheng J. Association between Hcy levels and the CBS844ins68 and MTHFR C677T polymorphisms with essential hypertension. Biomed Rep. 2014;2(6):861-8.

Le W-D, Xu P, Jankovic J, Jiang H, Appel SH, Smith RG, et al. Mutations in NR4A2 associated with familial Parkinson disease. Nat Genet. 2003;33(1):85-9.

Edinur HA, Dunn PPJ, Lea RA, Chambers GK. Molecular approaches to transfusion medicine in Polynesians and Maori in New Zealand. Int J Immunogenet. 2013;40(6):460-70.

Saleh RM, Zefarina Z, Mat NFC, Chambers GK, Edinur HA. Transfusion medicine and molecular genetic methods. Int J Prev Med. 2018;9:45.

Falzone L, Musso N, Gattuso G, Bongiorno D, Palermo CI, Scalia G, et al. Sensitivity assessment of droplet digital PCR for SARS-CoV-2 detection. Int J Mol Med. 2020;46(3):957-64.

Feder J, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, et al. A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996;13(4):399- 408.

Barton JC, Sawada-Hirai R, Rothenberg BE, Acton RT. Two novel missense mutations of the HFE gene (I105T and G93R) and identification of the S65C mutation in Alabama hemochromatosis probands. Blood Cells Mol Dis. 1999;25(3):147-55.

Ristić S, Makuc J, Starcevic N, Logar N, Brajenović-Milić B, Stepec S, et al. Hemochromatosis gene mutations in the Croatian and Slovenian populations. Clinil Genet. 2003;64(5):444-6.

Pedersen P, Melsen GV, Milman N. Frequencies of the haemochromatosis gene (HFE) variants C282Y, H63D and S65C in 6,020 ethnic Danish men. Ann Hematol. 2008;87:735-40.

Mariani R, Salvioni A, Corengia C, Erba N, Lanzafame C, Micheli, V De, et al. Prevalence of HFE mutations in upper Northern Italy: study of 1132 unrelated blood donors. Dig Liver Dis. 2003;35(7):479-81.

Beckman LE, Sjöberg K, Eriksson S, Beckman L. Haemochromatosis gene mutations in Finns, Swedes and Swedish Saamis. Hum Hered. 2001;52(2):110-2.

Mikhaĭlova SV, Kobzev VF, Kulikov IV, Romashchenko AG, Khasnulin VI, Voevoda MI. Polymorphism of the HFE gene associated with hereditary hemochromatosis in populations of Russia. Genetika. 2003;39(7):988-95.

Altes A, Ruiz A, Barceló MJ, Remacha AF, Puig T, Maya AJ, et al. Prevalence of the C282Y, H63D, and S65C mutations of the HFE gene in 1,146 newborns from a region of Northern Spain. Genet Test. 2004;8(4):407-10.

Alsmadi OA, Al-Kayal F, Al-Hamed M, Meyer BF. Frequency of common HFEvariants in the Saudi population: a high throughput molecular beacon- based study. BMC Med Genet. 2006;7(1):43.

Spínola H, Bruges-Armas J, Mora MG, Middleton D, Brehm A. HLA genes in Madeira Island (Portugal) inferred from sequence-based typing: Footprints from different origins. Mol Immunol. 2006;43(10):1726-8.

Kucinskas L, Juzenas S, Sventoraityte J, Cedaviciute R, Vitkauskiene A, Kalibatas V, et al. Prevalence of C282Y, H63D, and S65C mutations in hereditary HFE-hemochromatosis gene in Lithuanian population. Ann Hematol. 2012;91(4):491-5.

Ivanova A, von Ahsen N, Adjarov D, Krastev Z, Oellerich M, Wieland E. C282Y and H63D mutations in the HFE gene are not associated with porphyria cutanea tarda in bulgaria. Hepatology. 1999;30:1531-2.

Alkhateeb A, Uzrail A, Bodoor K. Frequency of the hemochromatosis gene (HFE) variants in a Jordanian Arab population and in diabetics from the same region. Dis Markers. 2009;27(1):17-22.

Khusainova RI, Khusnutdinova NN, Khusnutdinova EK. Analysis of the hemochromatosis gene (HFE) mutations, C282Y and H63D, in the populations of Central Asia. Russ J Genet. 2006;42(3):333-8.

Edinur HA, Zafarina Z, Spínola H, Nurhaslindawaty AR, Panneerchelvam S, Norazmi M-N. HLA polymorphism in six Malay subethnic groups in Malaysia. Hum Immunol. 2009;70(7):518-26.

Norhalifah HK, Syaza FH, Chambers GK, Edinur HA. The genetic history of Peninsular Malaysia. Gene. 2016;586(1):129-35.

Wan Syafawati WU, Norhalifah HK, Zefarina Z, Zafarina Z, Panneerchelvam S, Norazmi MN, et al. Allele frequencies of human platelet antigens in Banjar, Bugis, Champa, Jawa and Kelantan Malays in Peninsular Malaysia. Transfus Med. 2015;25(5):326-32.

Abd Gani R, Manaf SM, Zafarina Z, Panneerchelvam S, Chambers GK, Norazmi MN, Edinur HA. Molecular blood group typing in Banjar, Jawa, Mandailing and Kelantan Malays in Peninsular Malaysia. Transfus Apher Sci. 2015;53(1):69-73.

Norhalifah HK, Zafarina Z, Sundararajulu P, Norazmi MN, Edinur HA. Distribution of cytokine gene polymorphisms in five Malay subethnic groups in Peninsular Malaysia. Int J Immunogenet. 2015;42(3):200-3.

Manaf SM, NurWaliyuddin HZA, Panneerchelvam S, Zafarina Z, Norazmi MN, Chambers GK, et al. Human neutrophil antigen profiles in Banjar, Bugis, Champa, Jawa and Kelantan Malays in Peninsular Malaysia. Blood Transfus. 2015;13(4):610-5.

Hakim HM, Lalung J, Narayanen S, Khaw NR, Chamber GK, Edinur HA. A new analysis of population history in Sabah and Sarawak. Global J Bus Soc Sci Review. 2018;6:106-13.

Hakim HM, Khan HO, Ismail SA, Lalung J, Kofi AE, Abdullah MT, et al. Forensic parameters and ancestral fractions in the Kedayan population inferred using 21 autosomal STR loci. Meta Gene. 2020;25:100741.

Syafawati WUW, Zefarina Z, Zafarina Z, Hassan MN, Norazmi MN, Panneerchelvam S, et al. Human platelet antigen allelic diversity in Peninsular Malaysia. Immunohematology. 2016;32(4):143-60.

Manaf S, Panneerchelvam S, Norazmi MN, Zafarina Z, Edinur H. HNA diversity in six subgroups of Orang Asli in Peninsular Malaysia. Transfus Med. 2016;26(4):305-7.

Norhalifah HK, Syafawati WUW, Mat NFC, Chambers GK, Edinur HA. Distribution of cytokine gene polymorphisms in six Orang Asli subgroups in Peninsular Malaysia. Hum Immunol. 2016;77(4):338-9.

Edinur HA, Rasudin NS, Ghafar NA, Chambers GK. Advances in Medicine and Biology: the Austronesian diaspora from an HLA perspective: Nova Science Publishers Inc; 2017